Overcoming barriers to highly selective multi-tissue senolytic therapeutics.
open
Australia, Oceania
WS03110
Current approaches to highly selective multi-tissue senolytic therapeutics either underperform under variable field conditions or generate externalities that undermine long-term sustainability and equity. Closing the gap requires coordinated advances in science, systems design and enabling institutions.